← Leaderboards
Maxine L Stitzer
Johns Hopkins University
$35,973,273
Attributed
$44,207,470
Total exposure
14
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$44,207,470 · 14
By mechanism
U10$22,984,363 · 1
R01$12,689,532 · 9
UG1$8,027,412 · 1
P50$385,116 · 1
R13$121,047 · 1
M01$0 · 1
Top collaborators
- Robert P Schwartz24 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert A Wood$78,863,893
- Dean Foster Wong$23,186,974
- Mary E McCaul$21,975,059
- Claudia Michelle Campbell$14,946,130
- Renan C Castillo$6,430,047
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsBehavior TherapyBasePharmaceutical PreparationsSiteContingency ManagementUniversitiesDrug AbuseEffectivenessProgramsTrainingParticipantClinical Trials NetworkHuman SubjectEnrollmentFutureCaringCounselingTreatment ProgramCommunitiesMedical SchoolsProviderFacultyHealth Personnel
Grant awards (76)
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$1,238,610
UG1 · FY2019 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$813,278
UG1 · FY2018 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$331,605
UG1 · FY2018 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$765,680
UG1 · FY2017 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$720,392
UG1 · FY2017 · DA · contact PI
Clinical Trials Network: Mid Atlantic Integrated Care Research Collaborative$593,648
UG1 · FY2017 · DA · contact PI
Bupropion-Enhanced CM for Cocaine Dependence$528,297
R01 · FY2017 · DA · contact PI
Clinical Trials Network: Mid Atlantic Integrated Care Research Collaborative$405,292
UG1 · FY2017 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$786,413
UG1 · FY2016 · DA · contact PI
Bupropion-Enhanced CM for Cocaine Dependence$527,638
R01 · FY2016 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$422,557
UG1 · FY2016 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$417,308
UG1 · FY2016 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$1,144,797
U10 · FY2015 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$842,860
UG1 · FY2015 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$385,038
UG1 · FY2015 · DA · contact PI
Clinical Trials Network: Mid-Atlantic Integrated Care Research Collaborative$304,731
UG1 · FY2015 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$72,245
U10 · FY2015 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$1,131,521
U10 · FY2014 · DA · contact PI
Bupropion-Enhanced CM for Cocaine Dependence$546,816
R01 · FY2014 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$415,642
U10 · FY2014 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$1,134,513
U10 · FY2013 · DA · contact PI
Bupropion-Enhanced CM for Cocaine Dependence$558,721
R01 · FY2013 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$1,148,625
U10 · FY2012 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$693,662
U10 · FY2012 · DA · contact PI
Multisite Controlled Trial of Cocaine Vaccine (3 of 6) Baltimore Treatment Site$331,632
R01 · FY2012 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$1,147,669
U10 · FY2011 · DA · contact PI
Multisite Controlled Trial of Cocaine Vaccine (3 of 6) Baltimore Treatment Site$391,265
R01 · FY2011 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$238,372
U10 · FY2011 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$151,445
U10 · FY2011 · DA · contact PI
Clinical Trials Network Mid-Atlantic Collaborative Group$1,162,492
U10 · FY2010 · DA · contact PI
Improving Care Continuity in Drug Abuse Treatment$503,729
R01 · FY2010 · DA · contact PI
Clinical Trials Network-Mid-Atlantic Collaborative Group$1,250,000
U10 · FY2009 · DA · contact PI
Improving Care Continuity in Drug Abuse Treatment$479,911
R01 · FY2009 · DA · contact PI
Clinical Trials Network-Mid-Atlantic Collaborative Group$83,897
U10 · FY2009 · DA · contact PI
Clinical Trials Network-Mid-Atlantic Collaborative Group$1,250,000
U10 · FY2008 · DA · contact PI
Multisite Controlled Trial of Cocaine Vaccine (3 of 6) Baltimore Treatment Site$366,696
R01 · FY2008 · DA · contact PI
Clinical Trials Network-Mid-Atlantic Collaborative Group$850,000
U10 · FY2007 · DA · contact PI
Clinical Trials Network-Mid-Atlantic Collaborative Group$1,250,000
U10 · FY2006 · DA · contact PI
Clinical Trials Network-Mid-Atlantic Collaborative Group$786,582
U10 · FY2006 · DA · contact PI
Experimental Analysis of Smoking Relapse$355,238
R01 · FY2006 · CA · contact PI
Clinical Trials Network-Mid-Atlantic Collaborative Group$1,200,000
U10 · FY2005 · DA
Experimental Analysis of Smoking Relapse$363,788
R01 · FY2005 · CA
RECOVERY HOUSING AND DRUG ABUSE TREATMENT OUTCOMES$338,234
R01 · FY2005 · DA
CLINICAL TRIALS NETWORK MID-ATLANTIC COLLABORATIVE GROUP$200,000
U10 · FY2005 · DA
CLINICAL TRIALS NETWORK MID-ATLANTIC COLLABORATIVE GROUP$1,500,000
U10 · FY2004 · DA
RECOVERY HOUSING AND DRUG ABUSE TREATMENT OUTCOMES$522,174
R01 · FY2004 · DA
Experimental Analysis of Smoking Relapse$363,788
R01 · FY2004 · CA
CLINICAL TRIALS NETWORK MID-ATLANTIC COLLABORATIVE GROUP$343,750
U10 · FY2004 · DA
PARAMETRIC STUDIES OF DRUG ABUSE ABSTINENCE INCENTIVES$316,074
R01 · FY2004 · DA
CLINICAL TRIALS NETWORK MID-ATLANTIC COLLABORATIVE GROUP$1,500,000
U10 · FY2003 · DA
RECOVERY HOUSING AND DRUG ABUSE TREATMENT OUTCOMES$505,996
R01 · FY2003 · DA
Experimental Analysis of Smoking Relapse$363,788
R01 · FY2003 · CA
PARAMETRIC STUDIES OF DRUG ABUSE ABSTINENCE INCENTIVES$316,074
R01 · FY2003 · DA
CLINICAL TRIALS NETWORK MID-ATLANTIC COLLABORATIVE GROUP$285,001
U10 · FY2003 · DA
CLINICAL TRIALS NETWORK MID-ATLANTIC COLLABORATIVE GROUP$1,800,000
U10 · FY2002 · DA
PARAMETRIC STUDIES OF DRUG ABUSE ABSTINENCE INCENTIVES$620,612
R01 · FY2002 · DA
RECOVERY HOUSING AND DRUG ABUSE TREATMENT OUTCOMES$490,559
R01 · FY2002 · DA
Experimental Analysis of Smoking Relapse$363,788
R01 · FY2002 · CA
NOVEL LAPSE-RESPONSIVE APPROACH TO SMOKING CESSATION$327,000
R01 · FY2002 · DA
CLINICAL TRIALS NETWORK MID-ATLANTIC COLLABORATIVE GROUP$294,150
U10 · FY2002 · DA
SOCIETY FOR RESEARCH ON NICOTINE AND TOBACCO ANN MEETING$41,146
R13 · FY2002 · DA
HEROIN REINFORCEMENT DURING METHADONE TREATMENT$0
P50 · FY2002 · DA
CLINICAL TRIALS NETWORK MID-ATLANTIC COLLABORATIVE GROUP$1,950,000
U10 · FY2001 · DA
PARAMETRIC STUDIES OF DRUG ABUSE ABSTINENCE INCENTIVES$604,577
R01 · FY2001 · DA
RECOVERY HOUSING AND DRUG ABUSE TREATMENT OUTCOMES$442,257
R01 · FY2001 · DA
NOVEL LAPSE-RESPONSIVE APPROACH TO SMOKING CESSATION$327,000
R01 · FY2001 · DA
SOCIETY FOR RESEARCH ON NICOTINE AND TOBACCO ANN MEETING$40,341
R13 · FY2001 · DA
HEROIN REINFORCEMENT DURING METHADONE TREATMENT$0
P50 · FY2001 · DA
OUTPATIENT TREATMENT FOR IV DRUG ABUSERS$763,703
R01 · FY2000 · DA
PARAMETRIC STUDIES OF DRUG ABUSE ABSTINENCE INCENTIVES$589,588
R01 · FY2000 · DA
HEROIN REINFORCEMENT DURING METHADONE TREATMENT$385,116
P50 · FY2000 · DA
NOVEL LAPSE-RESPONSIVE APPROACH TO SMOKING CESSATION$323,653
R01 · FY2000 · DA
BEHAVIOR THERAPY FOR INNER CITY IV HEROIN ABUSERS$156,936
R01 · FY2000 · DA
SOCIETY FOR RESEARCH ON NICOTINE AND TOBACCO ANN MEETING$39,560
R13 · FY2000 · DA
TRYPTOPHAN AND BEHAVIOR THERAPY FOR COCAINE ABUSE$0
M01 · FY2000 · RR
TRYPTOPHAN AND BEHAVIOR THERAPY FOR COCAINE ABUSE$0
M01 · FY2000 · RR